Drug Development advanced
Peptide Ophthalmic Drug Development
Development of peptide therapeutics for eye diseases including formulation challenges. This peptide or oligopeptide is studied for its biological activity, s...
By Encyclopeptide Editorial | 1 min read
ophthalmic drug-development formulation clinical-trials eye-disease
Overview
Developing peptide therapeutics for ophthalmic applications requires overcoming unique challenges related to ocular anatomy.
Formulation Challenges
- Corneal epithelium barrier
- Tear film dilution
- Nasolacrimal drainage
- Enzymatic degradation
Delivery Strategies
- Topical: Eye drops, gels, inserts
- Intravitreal: Direct retinal delivery
- Periocular: Subconjunctival injection
- Systemic: For posterior segment disease
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Ophthalmic Drug Development |
| Category | Drug Development |
References
- Encyclopeptide Database. “Peptide Ophthalmic Drug Development” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Ophthalmic Drug Development with interactive quizzes on Wikipept.
Take a Quiz on Wikipept